The use of rapamycin in patients with tuberous sclerosis complex: Long-term results

Canpolat M., Gümüş H., Kumandaş S., Coşkun A., Per H.

EPILEPSY & BEHAVIOR, cilt.88, ss.357-364, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 88
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.yebeh.2018.09.020
  • Dergi Adı: EPILEPSY & BEHAVIOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.357-364
  • Anahtar Kelimeler: Rapamycin, Tuberous sclerosis, Epilepsy, mTOR, Child, GIANT-CELL ASTROCYTOMAS, MAMMALIAN TARGET, MTOR INHIBITORS, ADJUNCTIVE EVEROLIMUS, RISK-FACTORS, DOUBLE-BLIND, EPILEPSY, CHILDREN, MANAGEMENT, THERAPY
  • Erciyes Üniversitesi Adresli: Evet

Özet

Purpose: The purpose of this study was to evaluate the long-term results of eight cases diagnosed with tuberous sclerosis complex (TSC) and receiving rapamycin therapy because of epileptic seizures and/or accompanying TSC findings.